News

Filter

Current filters:

Simulect

1 to 9 of 31 results

Cerimon begins Ph II POC trial for eye inflammation disease

14-07-2008

San Francisco, USA-based Cerimon Pharmaceuticals has initiated a Phase II proof-of-concept study of Simulect…

BasiliximabNovartisNystatinOralSimulect

Astellas' says Advagraf represents step forward in post-transplant adherence

08-10-2007

The problem of non-adherence to immunosuppressive anti-rejection regimens by transplant recipients is…

BasiliximabCyclosporineNeoralNovartisPrografProtopicSimulecttacrolimus

SangStat transplant trial halted early

18-03-2002

SangStat has brought a comparative study of its transplant drugThymoglobulin (anti-thymocyte globulin…

BasiliximabNovartisSimulect

Novartis gets CPMP OK for pediatric Simulect

23-08-2000

Novartis says it has received backing from the European MedicinesEvaluation Agency's Committee for Proprietary…

BasiliximabCyclosporineNeoralNovartisRestasisSandimmuneSimulect

Ligand sells Marathon assets for $10 million

11-01-2000

Ligand Pharmaceuticals says it has sold the assets of its contractmanufacturing subsidiary Marathon Biopharmaceuticals…

AlitretinoinBasiliximabbexarotenedaclizumabDenileukin DiftitoxNovartisOntakPanretinRocheSimulectTargretinZenapax

Cash boost for Ligand as Elan raises stake

04-01-2000

Ligand Pharmaceuticals says that Ireland's Elan Corp has converted thezero coupon convertible note that…

BasiliximabbexarotenedaclizumabNovartisNystatinOralRocheSimulectTargretinZenapax

Novartis plans to maintain tight grip on organ transplantation market

11-10-1999

One of the key underpinnings of the success of Swiss life sciences groupNovartis has been its blockbusting…

BasiliximabCyclosporineNeoralNovartisPrografProtopicRapamuneRestasisSandimmuneSimulectsirolimustacrolimus

1 to 9 of 31 results

COMPANY SPOTLIGHT

Menarini

Back to top